IL17A and rheumatoid arthritis: Considering the roles of Th17 cells and IL-17 in causing excess inflammation during the development of RA, our results suggest that Ssu72 may represent a novel therapeutic modality for regulating the differentiation of Th1 or Th2 cells in the treatment of RA.